The delay follows leadership changes within the FDA. Dr. Scott Steele has been appointed acting director of the agency’s ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...

After the gutting of the Department of Health and Human Services, fears mount about the future direction of the FDA—with ...

Novavax shifts to a partnership-focused strategy with a $500M Sanofi deal. Despite regulatory and competitive risks. See why ...

Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, declaring that single antigen ...

The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...

The surprise delay is casting new uncertainty ... to roll up one sleeve’ If a flu+Covid combination vaccine does eventually get FDA approval, it might help improve vaccination rates because ...

But full FDA approval would allow the vaccine to be used more widely and could offer more reassurance to people looking for options besides the existing mRNA vaccines, CNN reported. The delay ...